Evidence map›Paper›PMID 33872541›Full record

ArticleAnnals of internal medicine2021

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.

Julia Del Amo, Rosa Polo, Santiago Moreno, Asunción Díaz, Esteban Martínez, José Ramón Arribas, Inma Jarrín, Miguel A Hernán

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Observational
  8. Review
  9. Article
  10. Article
  11. COVID-19 in people living with HIV: A multicenter case-series study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Regional vulnerability for COVID-19 in Cameroon.The Pan African medical journal · 2020
    Article
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Julia Del AmoMinistry of Health, Madrid, Spain.
Rosa PoloMinistry of Health, Madrid, Spain.
Santiago MorenoUniversity Hospital Ramón y Cajal and HIV Network of Excellence, Madrid, Spain.
Asunción DíazInstitute of Health Carlos III, Ministry of Health, and HIV Network of Excellence, Madrid, Spain.ORCID 0000-0002-8309-4270
Esteban MartínezUniversity Hospital Clinic, Barcelona, Spain, and HIV Network of Excellence, Madrid, Spain.ORCID 0000-0002-7410-9450
José Ramón ArribasUniversity Hospital La Paz, IdiPAZ, and HIV Network of Excellence, Madrid, Spain.
Inma JarrínInstitute of Health Carlos III and HIV Network of Excellence, Madrid, Spain.
Miguel A HernánHarvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts.ORCID 0000-0003-1619-8456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HIV InfectionsAntiretroviral Therapy, Highly ActiveHumansIncidenceSARS-CoV-2

Identifiers

PMID33872541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.